Navigation Links
Allscripts Named to FORTUNE 100 Fastest-Growing Companies List

Strong Revenue Growth, Driven by Growing Demand for Healthcare Information Technology, Places Allscripts 23rd among America's Top Corporate Performers

CHICAGO, Sept. 7 /PRNewswire-FirstCall/ -- Allscripts (Nasdaq: MDRX), the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare, today announced that it was named one of FORTUNE magazine's 100 Fastest-Growing Companies for 2007. The list, comprised of public companies, appears in the September 17, 2007 issue of FORTUNE and is available online now at Allscripts, which was ranked No. 23 overall, was one of only seven companies in the healthcare sector to make this year's list.

(Logo: )

"We are pleased to be recognized as one of Fortune's 100 Fastest-Growing Companies for 2007," said Glen Tullman, Chief Executive Officer of Allscripts. "We have experienced strong growth across all of our business lines, which is a great tribute to our organization and the people on the front lines who deliver day in and day out for our clients. It is becoming increasingly clear that information technology is the solution of choice for solving the challenges we face in our healthcare system, and that Allscripts is the go-to company for these solutions."

FORTUNE joined with Zacks Investment Research to compile the list of the 100 Fastest-Growing Companies. In order to qualify for this year's listing, a company must be incorporated in the U.S.; have a minimum market capitalization of $250 million; have a stock price of at least $5; have been trading continuously since June 30, 2004; have revenue and net income for the four quarters ended on or before May 31, 2007 of at least $50 million and $10 million, respectively; and have posted a compound annual growth in revenue and earnings per share of at least 25 percent annually over the three years ended on or before May 31, 2007. All companies that met these criteria were ranked by their revenue growth rate; their EPS growth rate; and their three-year annualized total return to investors for the period ended June 30, 2007.

About Allscripts

Allscripts is the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare. The Company's business units provide unique solutions that inform, connect and transform healthcare. Allscripts award-winning software applications include Electronic Health Records, practice management, e-prescribing, document imaging, emergency department, and care management solutions, all offered through the Company's Clinical Solutions units. Additionally, Allscripts provides clinical product education and connectivity solutions for physicians and patients through its Physicians Interactive(TM) unit, and medication fulfillment services through its Medication Services unit. To learn more, visit Allscripts on the Web at

This announcement may contain forward-looking statements about Allscripts Healthcare Solutions that involve risks and uncertainties. These statements are developed by combining currently available information with Allscripts beliefs and assumptions. Forward-looking statements do not guarantee future performance. Because Allscripts cannot predict all of the risks and uncertainties that may affect it, or control the ones it does predict, Allscripts' actual results may be materially different from the results expressed in its forward-looking statements. For a more complete discussion of the risks, uncertainties and assumptions that may affect Allscripts, see the Company's 2006 Annual Report on Form 10-K, available through the Web site maintained by the Securities and Exchange Commission at

SOURCE Allscripts
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. UP government decides to suspend doctor named in sting operation
2. Yale Researchers Named Ellison Foundation Senior Scholars in Aging
3. Brian Lara Opens Cancer Center Named After Him
4. Bat Virus Renamed After Protests from Malaysia State
5. Our Attitude To Food Costing Us A Fortune
6. A brush with the U.S. Regulators can cost a fortune
7. Waiting list in British healthcare causing them to shell out a fortune!
8. India to benefit from pharma companies move
9. Doctors not to accept gifts from drug companies
10. Pharmaceutical companies are targeting patients
11. FDA To Set New Guidelines To Revise Drug Companies Marketing Tactics
Post Your Comments:
(Date:11/27/2015)... ... November 28, 2015 , ... There is only one major question facing ... last year? , This question has not been an easy question to answer. Especially ... age and the younger workforce don’t share the same discipline around working long hours. ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... study carried out by the University of Toronto and the University of British Columbia ... of hospitalizations for head injuries. The article explains that part of the reason for ...
(Date:11/27/2015)... ... November 27, 2015 , ... The ... in America. As people age, more care is needed, especially with Alzheimer’s, dementia ... medical professionals are being overworked. The forgotten part of this equation: 80 percent ...
(Date:11/27/2015)... ... November 27, 2015 , ... An inventor, ... to dispense prescription medications at home, so he invented the patent-pending ELECTRONIC M.D. ... dispense prescription medications. In doing so, it could help to prevent potential overdose ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... Lizzie’s ... , The company is offering customers 10% off of their purchase of lice treatment ... treatment at full price. According to a company spokesperson. “Finding lice is a sure ...
Breaking Medicine News(10 mins):
(Date:11/29/2015)... Nov. 29, 2015  The GE Health Cloud 1 ... Society of North America (RSNA) meeting ... healthcare industry, the new cloud ecosystem and its applications will ... care pathways and multidisciplinary teams – both inside and outside ... and CEO of GE. "As the digital industrial leader, we ...
(Date:11/27/2015)... 27, 2015 Une nouvelle ... au Bremachlorin contre le cancer avancé.    ... combiner l,immunothérapie au traitement photodynamique au Bremachlorin contre ... Une nouvelle approche consistant à combiner l,immunothérapie ... avancé.    Clinical Cancer Research ...
(Date:11/27/2015)... 2015  Lannett Company, Inc. (NYSE: LCI ... acquisition of Kremers Urban Pharmaceuticals Inc. (KU), the ... company UCB S.A. (Euronext: UCB). ... KU from UCB for total consideration of approximately ... customary working capital adjustment, a deduction of certain ...
Breaking Medicine Technology: